CannaPharmaRx Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 26

Employees

  • Stock Symbol
  • CPMD

Stock Symbol

  • Investments
  • 8

CannaPharmaRx General Information

Description

Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canada. The group evolved to focus on producing medical cannabis and craft products. The products of the company are Unique Genetics, Craft Products, and Medical Cannabis.

Contact Information

Website
www.cannapharmarx.com
Formerly Known As
Cavion Technologies, Golden Dragon Holding Co., Cavion Technologies Inc, Ccvg, Inc.
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 888 3rd Street Southwest
  • Suite 3600
  • Calgary, Alberta T2P 5C5
  • Canada
+1 (856)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
OTCM
Vertical(s)
Cannabis, LOHAS & Wellness
Corporate Office
  • 888 3rd Street Southwest
  • Suite 3600
  • Calgary, Alberta T2P 5C5
  • Canada
+1 (856)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CannaPharmaRx Stock Performance

As of 13-Nov-2026, CannaPharmaRx’s current market cap is $1.42M with 709M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.42M 709M 192K -$0.01

CannaPharmaRx Financials Summary

As of 30-Jun-2026, CannaPharmaRx has a trailing 12-month revenue of $1.7M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 23,231 24,093 20,388 19,625
Revenue 1,699 1,362 820 0
EBITDA (8,712) (8,628) (7,364) 5,507
Net Income (11,318) (11,131) (9,906) 3,688
Total Assets 6,892 7,018 10,836 11,746
Total Debt 20,633 20,650 14,060 12,935
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CannaPharmaRx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CannaPharmaRx‘s full profile, request access.

Request a free trial

CannaPharmaRx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cannapharmarx Inc specializes in the acquisition, development, and operation of cannabis cultivation facilities in Canad
Drug Discovery
Calgary, Canada
26 As of 2025

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CannaPharmaRx Competitors (1)

One of CannaPharmaRx’s competitors is Avicanna, a Formerly VC-backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Avicanna Formerly VC-backed Toronto, Canada
You’re viewing 1 of 1 competitors. Get the full list »

CannaPharmaRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CannaPharmaRx Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CannaPharmaRx‘s full profile, request access.

Request a free trial

CannaPharmaRx Investments & Acquisitions (8)

CannaPharmaRx’s most recent deal was a Merger/Acquisition with LTB Management. The deal was made on 21-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LTB Management 21-Mar-2023 Merger/Acquisition Financial Software
Klonetics 16-Dec-2021 Early Stage VC Cultivation
CannaPharmaRx (97,000 Square Foot Facility in Sasksatoon, Canada) 28-Jan-2021 Corporate Asset Purchase Buildings and Property
CannapharmaRx (Fee Simple Lands and Facility in Cremona, Alberta) 07-Jan-2021 Corporate Asset Purchase Buildings and Property
CannaPharmaRx (Cannabis Facility in Cathedral City, California) 07-Jul-2020 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

CannaPharmaRx ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view CannaPharmaRx’s complete esg history, request access »

CannaPharmaRx Exits (1)

CannaPharmaRx’s most recent exit was on 16-Dec-2021 from Klonetics. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Klonetics 16-Dec-2021 Completed
  • 2 buyers
To view CannaPharmaRx’s complete exits history, request access »

CannaPharmaRx FAQs

  • When was CannaPharmaRx founded?

    CannaPharmaRx was founded in 1998.

  • Where is CannaPharmaRx headquartered?

    CannaPharmaRx is headquartered in Calgary, Canada.

  • What is the size of CannaPharmaRx?

    CannaPharmaRx has 26 total employees.

  • What industry is CannaPharmaRx in?

    CannaPharmaRx’s primary industry is Drug Discovery.

  • Is CannaPharmaRx a private or public company?

    CannaPharmaRx is a Public company.

  • What is CannaPharmaRx’s stock symbol?

    The ticker symbol for CannaPharmaRx is CPMD.

  • What is the current market cap of CannaPharmaRx?

    The current market capitalization of CannaPharmaRx is $1.42M.

  • What is CannaPharmaRx’s current revenue?

    The trailing twelve month revenue for CannaPharmaRx is $1.7M.

  • Who are CannaPharmaRx’s competitors?

    Avicanna is a competitor of CannaPharmaRx.

  • What is CannaPharmaRx’s annual earnings per share (EPS)?

    CannaPharmaRx’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process